Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Infect Dis ; 219(3): 497-508, 2019 01 09.
Article in English | MEDLINE | ID: mdl-30202890

ABSTRACT

Background: Human immunodeficiency virus (HIV) infection is an independent risk factor for coronary heart disease (CHD) and is associated with perturbation of the gut microbiota. Methods: We analyzed gut microbiota in 30 HIV-infected individuals with CHD (CHD+) and 30 without CHD (CHD-) of the HIV-HEART study group. Results: Gut microbiota linked to CHD was associated with lower α-diversity. Despite insignificant differences in ß-diversity, co-occurrence networks of bacterial genera clearly diverged between CHD+ and CHD- individuals. Multidimensional scaling separated HIV-infected individuals into 2 microbiome clusters, dominated by the genus Prevotella or Bacteroides. The relative abundance of 49 other genera was significantly different between both clusters. The Prevotella-rich cluster was largely composed of men who have sex with men (MSM) (97%), whereas the Bacteroides-rich cluster comprised both MSM (45%) and heterosexual individuals (55%). MSM of the Bacteroides-rich cluster were characterized by reduced α-diversity, advanced immunological HIV stage, longer antiretroviral therapy with more ART regimens, and longer use of protease inhibitors, compared with Prevotella-rich MSM. Conclusions: Community structures of gut microbiota rather than individual species might facilitate risk assessment of CHD in HIV-infected individuals. Sexual behavior appears to be an important factor affecting gut microbiota ß-diversity and should be considered in future studies.


Subject(s)
Biodiversity , Coronary Disease/complications , Gastrointestinal Microbiome , HIV Infections/complications , Adult , Aged , Bacteroides/genetics , Bacteroides/isolation & purification , Bacteroides/pathogenicity , Female , Homosexuality, Male , Humans , Male , Methylamines/pharmacology , Methylamines/therapeutic use , Middle Aged , Prevotella/genetics , Prevotella/isolation & purification , Prevotella/pathogenicity , Risk Factors , Sexual Behavior , Sexual and Gender Minorities
SELECTION OF CITATIONS
SEARCH DETAIL